BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 30461320)

  • 21. Landscape of Familial Isolated and Young-Onset Pituitary Adenomas: Prospective Diagnosis in AIP Mutation Carriers.
    Hernández-Ramírez LC; Gabrovska P; Dénes J; Stals K; Trivellin G; Tilley D; Ferrau F; Evanson J; Ellard S; Grossman AB; Roncaroli F; Gadelha MR; Korbonits M;
    J Clin Endocrinol Metab; 2015 Sep; 100(9):E1242-54. PubMed ID: 26186299
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Prevalence of AIP mutations in a large series of sporadic Italian acromegalic patients and evaluation of CDKN1B status in acromegalic patients with multiple endocrine neoplasia.
    Occhi G; Trivellin G; Ceccato F; De Lazzari P; Giorgi G; Demattè S; Grimaldi F; Castello R; Davì MV; Arnaldi G; Salviati L; Opocher G; Mantero F; Scaroni C
    Eur J Endocrinol; 2010 Sep; 163(3):369-76. PubMed ID: 20530095
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aryl hydrocarbon receptor interacting protein (AIP) mutations occur rarely in sporadic parathyroid adenomas.
    Pardi E; Marcocci C; Borsari S; Saponaro F; Torregrossa L; Tancredi M; Raspini B; Basolo F; Cetani F
    J Clin Endocrinol Metab; 2013 Jul; 98(7):2800-10. PubMed ID: 23633209
    [TBL] [Abstract][Full Text] [Related]  

  • 24. AIP mutations in young patients with acromegaly and the Tampico Giant: the Mexican experience.
    Ramírez-Rentería C; Hernández-Ramírez LC; Portocarrero-Ortiz L; Vargas G; Melgar V; Espinosa E; Espinosa-de-Los-Monteros AL; Sosa E; González B; Zúñiga S; Unterländer M; Burger J; Stals K; Bussell AM; Ellard S; Dang M; Iacovazzo D; Kapur S; Gabrovska P; Radian S; Roncaroli F; Korbonits M; Mercado M
    Endocrine; 2016 Aug; 53(2):402-11. PubMed ID: 27033541
    [TBL] [Abstract][Full Text] [Related]  

  • 25.
    Trofimiuk-Müldner M; Domagała B; Sokołowski G; Skalniak A; Hubalewska-Dydejczyk A
    Front Endocrinol (Lausanne); 2023; 14():1098367. PubMed ID: 36843582
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Should aip gene screening be recommended in family members of FIPA patients with R16H variant?
    Zatelli MC; Torre ML; Rossi R; Ragonese M; Trimarchi F; degli Uberti E; Cannavò S
    Pituitary; 2013 Jun; 16(2):238-44. PubMed ID: 22915287
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Whole-exome identifies RXRG and TH germline variants in familial isolated prolactinoma.
    Melo FM; Couto PP; Bale AE; Bastos-Rodrigues L; Passos FM; Lisboa RG; Ng JM; Curran T; Dias EP; Friedman E; De Marco L
    Cancer Genet; 2016 Jun; 209(6):251-7. PubMed ID: 27245436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Low frequency of AIP mutations in patients with young-onset sporadic pituitary macroadenomas.
    Gaspar LM; Gonçalves CI; Saraiva C; Cortez L; Amaral C; Nobre E; Lemos MC
    J Endocrinol Invest; 2023 Nov; 46(11):2299-2307. PubMed ID: 37149543
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Germline mutation in the aryl hydrocarbon receptor interacting protein gene in familial somatotropinoma.
    Toledo RA; Lourenço DM; Liberman B; Cunha-Neto MB; Cavalcanti MG; Moyses CB; Toledo SP; Dahia PL
    J Clin Endocrinol Metab; 2007 May; 92(5):1934-7. PubMed ID: 17341560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Familial isolated pituitary adenomas (FIPA) and the pituitary adenoma predisposition due to mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Beckers A; Aaltonen LA; Daly AF; Karhu A
    Endocr Rev; 2013 Apr; 34(2):239-77. PubMed ID: 23371967
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A Novel Mutation of Aryl Hydrocarbon Receptor Interacting Protein Gene Associated with Familial Isolated Pituitary Adenoma Mediates Tumor Invasion and Growth Hormone Hypersecretion.
    Cai F; Hong Y; Xu J; Wu Q; Reis C; Yan W; Wang W; Zhang J
    World Neurosurg; 2019 Mar; 123():e45-e59. PubMed ID: 30447469
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Aryl hydrocarbon receptor interacting protein gene (AIP) mutations are rare in patients with hormone secreting or non-secreting pituitary adenomas.
    Buchbinder S; Bierhaus A; Zorn M; Nawroth PP; Humpert P; Schilling T
    Exp Clin Endocrinol Diabetes; 2008 Nov; 116(10):625-8. PubMed ID: 18484068
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Differentiated thyroid carcinoma in sporadic and familial presentations of acromegaly: A case series.
    Rogozinski A; Daly AF; Reyes A; Furioso A; Beckers A; Lowenstein A
    Ann Endocrinol (Paris); 2020 Oct; 81(5):482-486. PubMed ID: 32822652
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Aryl hydrocarbon receptor-interacting protein gene mutations in familial isolated pituitary adenomas: analysis in 73 families.
    Daly AF; Vanbellinghen JF; Khoo SK; Jaffrain-Rea ML; Naves LA; Guitelman MA; Murat A; Emy P; Gimenez-Roqueplo AP; Tamburrano G; Raverot G; Barlier A; De Herder W; Penfornis A; Ciccarelli E; Estour B; Lecomte P; Gatta B; Chabre O; Sabaté MI; Bertagna X; Garcia Basavilbaso N; Stalldecker G; Colao A; Ferolla P; Wémeau JL; Caron P; Sadoul JL; Oneto A; Archambeaud F; Calender A; Sinilnikova O; Montañana CF; Cavagnini F; Hana V; Solano A; Delettieres D; Luccio-Camelo DC; Basso A; Rohmer V; Brue T; Bours V; Teh BT; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1891-6. PubMed ID: 17244780
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mutation analysis of inhibitory guanine nucleotide binding protein alpha (GNAI) loci in young and familial pituitary adenomas.
    Demir H; Donner I; Kivipelto L; Kuismin O; Schalin-Jäntti C; De Menis E; Karhu A
    PLoS One; 2014; 9(10):e109897. PubMed ID: 25291362
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical, pathological, and genetic features of familial isolated pituitary adenomas.
    Beckers A; Daly AF
    Eur J Endocrinol; 2007 Oct; 157(4):371-82. PubMed ID: 17893250
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Familial isolated pituitary adenomas (FIPA) and mutations in the aryl hydrocarbon receptor interacting protein (AIP) gene.
    Daly AF; Beckers A
    Endocrinol Metab Clin North Am; 2015 Mar; 44(1):19-25. PubMed ID: 25732638
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mutations in the aryl hydrocarbon receptor interacting protein gene are not highly prevalent among subjects with sporadic pituitary adenomas.
    Barlier A; Vanbellinghen JF; Daly AF; Silvy M; Jaffrain-Rea ML; Trouillas J; Tamagno G; Cazabat L; Bours V; Brue T; Enjalbert A; Beckers A
    J Clin Endocrinol Metab; 2007 May; 92(5):1952-5. PubMed ID: 17299063
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical experience in the screening and management of a large kindred with familial isolated pituitary adenoma due to an aryl hydrocarbon receptor interacting protein (AIP) mutation.
    Williams F; Hunter S; Bradley L; Chahal HS; Storr HL; Akker SA; Kumar AV; Orme SM; Evanson J; Abid N; Morrison PJ; Korbonits M; Atkinson AB
    J Clin Endocrinol Metab; 2014 Apr; 99(4):1122-31. PubMed ID: 24423289
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The aryl hydrocarbon receptor-interacting protein gene is rarely mutated in sporadic GH-secreting adenomas.
    Iwata T; Yamada S; Mizusawa N; Golam HM; Sano T; Yoshimoto K
    Clin Endocrinol (Oxf); 2007 Apr; 66(4):499-502. PubMed ID: 17371465
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.